SNN
USDSmith & Nephew SNATS Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$36.480
Kõrge
$37.080
Madal
$36.460
Maht
1.61M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
15.8B
Tööstusharu
Meditsiiniseadmed
Riik
United Kingdom
Kauplemisstatistika
Keskmine maht
0.67M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Seotud uudised
Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices
UFC® and Smith+Nephew announce multi-year extension of partnership
Smith+Nephew to continue as UFC's Preferred Sports Medicine Technology Partner Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world's premier mixed martial arts organization, have
Bernstein Downgrades Smith & Nephew to Market Perform, Announces $37.5 Price Target
Bernstein analyst Lisa Clive downgrades Smith & Nephew from Outperform to Market Perform and announces $37.5 price target.
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT)
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.